Refractive Surgery News

WAILEA, Hawaii — In this video from Hawaiian Eye 2021, Eric D. Donnenfeld, MD, discusses the potential of new-generation extended depth of focus IOLs.

Nyxol, an alpha 1/2 antagonist eye drop, helped reverse the effects of pharmacologically induced mydriasis in healthy subjects, according to a phase 3 study.

With continuing surgeon fee reductions in reimbursement for cataract surgery and a smaller corneal refractive surgery market, it may seem like an odd time to think about investing in new technology for your practice.

WAILEA, Hawaii — Keeping the promise of “no glasses after cataract surgery,” begins and ends with preoperative preparation and setting of expectations, according to a speaker at Hawaiian Eye 2021.

WAILEA, Hawaii — In this video from Hawaiian Eye, I. Paul Singh, MD, discusses how innovative technology has changed his definition of controlled glaucoma.

WAILEA, Hawaii — A new and anticipated UV-coated version of the Light Adjustable Lens is superior to the original LAL, according to a surgeon who shared the news for the first time here at Hawaiian Eye.

WAILEA, Hawaii — The AcrySof IQ Vivity IOL features less glare and fewer halos with “significantly fewer complaints” than previously studied multifocal IOLs, according to a speaker at Hawaiian Eye 2021.

WAILEA, Hawaii — In this video from Hawaiian Eye, Mitchell A. Jackson, MD, discusses how he has incorporated the use of Klarity-C from Imprimis in his preoperative regimen to help optimize the ocular surface prior to surgery.

WAILEA, Hawaii — At Hawaiian Eye 2021, Richard L. Lindstrom, MD, discusses his presentation on the progress being made by several companies toward pharmacological treatment of presbyopia.

Mark A. Bullimore, MCOptom, PhD, FAAO, FARVO, presented a poster at this year’s ARVO virtual meeting focused on the link between growing rates of myopia and projected visual impairment in the U.S.